Based on “kinetic segregation” and “TCR-pMHC ligation” model, we hypothesized that the intercellular CD45-CD45 dimerization could protect tumor cells from T cell recognition and killing by preventing CD45 exclusion from the MHC I-peptide-TCR complex34,35 (Fig. 7v). This evidence concerns the gene PTPRC and neoplasm.